Alan Wu, Ph.D., D.A.B.C.C.
Alan H.B. Wu, Ph.D., is Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital and Professor of Laboratory Medicine, University of California, San Francisco. He received a B.S. degree in chemistry and biology at Purdue University, West Lafayette, Indiana, and a Ph.D. degree in analytical chemistry at the University of Illinois, Champaign-Urbana, Illinois. He completed a postdoctoral fellowship in clinical chemistry at Hartford Hospital. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry.
Dr. Wu’s research interest has been in the fields of biochemical markers for cardiovascular disease including CK-MB, myoglobin, troponin, B-type natriuretic peptide, markers of myocardial ischemia, and stroke. He has published over 300 papers, abstracts, and book chapters in this field. He is author of Cardiac Markers, Totowa Press, Self Assessment in Clinical Laboratory Science, AACC Press, and Tietz Clinical Guide to Laboratory Tests, Elsevier Science. He is a member of the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline Committees on “Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases.”
Dr. Wu has served on several editorial boards including Clinical Chemistry, Annals of Clinical Laboratory Science, Point of Care, and since 1998, he is co-editor-in-chief for Clinica Chimica Acta. He is a member of the AACC Standardization subcommittees on CK-MB and cardiac troponin, and the International Federation of Clinical Chemistry Standardization of Markers of Cardiac Damage Committee.